/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Alaunos Therapeutics Inc. Share Price Today: Live Updates & Key Insights

Alaunos Therapeutics Inc. share price today is $3.2956, up -2.72%. The stock opened at $3.255 against the previous close of $3.31, with an intraday high of $3.255 and low of $3.1.

Alaunos Therapeutics Inc. Share Price Chart

style
pb-0

Alaunos Therapeutics Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Alaunos Therapeutics Inc. Share Price Performance

$3.2956 -0.0272(-2.72%) TCRT at 23 Mar 2026 03:27 PM Biotechnology
Lowest Today 3.1
Highest Today 3.255
Today’s Open 3.255
Prev. Close 3.31
52 Week High 5.48
52 Week Low 1.31
Day’s Range: Low 3.1 High 3.255
52-Week Range: Low 1.31 High 5.48
1 day return -
1 Week return -1.53
1 month return +18.45
3 month return -7.49
6 month return +30.48
1 year return +49.3
3 year return -55.54
5 year return -94.72
10 year return -

Alaunos Therapeutics Inc. Institutional Holdings

Vanguard Group Inc 1.35

BlackRock Inc 0.96

Geode Capital Management, LLC 0.88

Two Sigma Investments LLC 0.83

Vanguard Institutional Extnd Mkt Idx Tr 0.63

HRT FINANCIAL LLC 0.56

Fidelity Extended Market Index 0.56

Blackrock Extended Mkt Fund CF 0.15

Extended Equity Market Fund K 0.13

Fidelity Total Market Index 0.11

Fidelity Series Total Market Index 0.10

Morgan Stanley - Brokerage Accounts 0.08

UBS Group AG 0.07

Spartan Total Market Index Pool G 0.06

Northern Trust Extended Eq Market Idx 0.06

NT Ext Equity Mkt Idx Fd - L 0.06

Fidelity Nasdaq Composite Index 0.05

NT Ext Equity Mkt Idx Fd - NL 0.05

Tower Research Capital LLC 0.05

Advisor Group Holdings, Inc. 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

State St US Extended Mkt Indx NL Cl C 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Vanguard U.S. Eq Idx £ Acc 0.02

Extended Equity Market Fund M 0.01

SSgA U.S. Total Market Index Strategy 0.01

Atlantic Trust Group, LLC 0.01

Royal Bank of Canada 0.01

Wells Fargo & Co 0.01

State St US Ttl Mkt Indx NL Cl A 0.01

Northern Trust Wilshire 5000 0.01

NT US Market Cap Idx Fd - L 0.01

Ronald Blue Trust, Inc. 0.01

Steward Partners Investment Advisory, LLC 0.00

Bank of America Corp 0.00

Federation des caisses Desjardins du Quebec 0.00

Barclays PLC 0.00

KEY Financial, INC. 0.00

SignatureFD, LLC 0.00

Newbridge Financial Services Group, Inc. 0.00

Alaunos Therapeutics Inc. Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Alaunos Therapeutics Inc. Fundamentals

Market Cap 7.19 M

PB Ratio 2.5639

PE Ratio 0.0

Enterprise Value 1.12 M

Total Assets 2.76 M

Volume 29170

Alaunos Therapeutics Inc. Company Financials

Annual Revenue FY23:15000 0.0M, FY22:2922000 2.9M, FY21:398000 0.4M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:2922000 2.9M, FY21:-342000 -0.3M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-36456000 -36.5M, FY22:-37597000 -37.6M, FY21:-76894000 -76.9M, FY20:-78848000 -78.8M, FY19:-177918000 -177.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:2000 0.0M, Q3/2024:0 0.0M, Q2/2024:4000 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-185000 -0.2M, Q1/2025:2000 0.0M, Q3/2024:null 0.0M, Q2/2024:3000 0.0M

Quarterly Net worth Q3/2025:-1159000 -1.2M, Q2/2025:-1051000 -1.1M, Q1/2025:-1073000 -1.1M, Q3/2024:-1127000 -1.1M, Q2/2024:-1129000 -1.1M

About Alaunos Therapeutics Inc. & investment objective

Company Information Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

Organisation Biotechnology

Employees 1

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Alaunos Therapeutics Inc. FAQs

What is the share price of Alaunos Therapeutics Inc. today?

The current share price of Alaunos Therapeutics Inc. is $3.2956.

Can I buy Alaunos Therapeutics Inc. shares in India?

Yes, Indian investors can buy Alaunos Therapeutics Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Alaunos Therapeutics Inc. shares in India?

You can easily invest in Alaunos Therapeutics Inc. shares from India by:

Can I buy fractional shares of Alaunos Therapeutics Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Alaunos Therapeutics Inc.?

Alaunos Therapeutics Inc. has a market cap of $7.19 M.

In which sector does Alaunos Therapeutics Inc. belong?

Alaunos Therapeutics Inc. operates in the Biotechnology sector.

What documents are required to invest in Alaunos Therapeutics Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Alaunos Therapeutics Inc.?

The PE ratio of Alaunos Therapeutics Inc. is N/A and the PB ratio is 2.56.